US 7763590
Compositions and methods for inhibiting expression of a mutant gene
granted A61PA61P35/00
Quick answer
US patent 7763590 (Compositions and methods for inhibiting expression of a mutant gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00